Citadel Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.8M Sell
1,684,300
-358,000
-18% -$1.87M ﹤0.01% 3618
2025
Q4
$10.2M Sell
2,042,300
-304,000
-13% -$1.58M ﹤0.01% 3232
2025
Q3
$11.9M Buy
2,346,300
+453,600
+24% +$2M ﹤0.01% 3005
2025
Q2
$8.16M Sell
1,892,700
-228,100
-11% -$1.13M ﹤0.01% 3327
2025
Q1
$12.8M Sell
2,120,800
-1,239,200
-37% -$6.27M ﹤0.01% 2546
2024
Q4
$13.3M Sell
3,360,000
-211,800
-6% -$949K ﹤0.01% 2622
2024
Q3
$20.9M Buy
3,571,800
+782,200
+28% +$3.86M ﹤0.01% 2009
2024
Q2
$12M Buy
2,789,600
+715,000
+34% +$3.43M ﹤0.01% 2546
2024
Q1
$9.75M Buy
2,074,600
+84,000
+4% +$322K ﹤0.01% 2983
2023
Q4
$9.77M Sell
1,990,600
-566,800
-22% -$2.78M ﹤0.01% 2876
2023
Q3
$13.9M Sell
2,557,400
-806,300
-24% -$6.46M ﹤0.01% 2278
2023
Q2
$31.1M Sell
3,363,700
-2,222,500
-40% -$18.8M 0.01% 1437
2023
Q1
$45.9M Buy
5,586,200
+2,004,600
+56% +$22.1M 0.01% 1149
2022
Q4
$39.9M Buy
3,581,600
+917,500
+34% +$10.7M 0.01% 1303
2022
Q3
$31.6M Buy
2,664,100
+2,376,600
+827% +$36M 0.01% 1425
2022
Q2
$4.39M Buy
287,500
+102,000
+55% +$1.84M ﹤0.01% 4058
2022
Q1
$3.92M Buy
185,500
+31,900
+21% +$687K ﹤0.01% 4650
2021
Q4
$3.63M Sell
153,600
-160,500
-51% -$3.44M ﹤0.01% 4951
2021
Q3
$6.3M Sell
314,100
-28,200
-8% -$578K ﹤0.01% 3878
2021
Q2
$6.88M Buy
342,300
+193,700
+130% +$4.14M ﹤0.01% 3771
2021
Q1
$3.16M Buy
148,600
+51,600
+53% +$1.11M ﹤0.01% 5315
2020
Q4
$2.11M Buy
97,000
+42,300
+77% +$824K ﹤0.01% 5249
2020
Q3
$964K Sell
54,700
-12,600
-19% -$234K ﹤0.01% 6099
2020
Q2
$1.26M Sell
67,300
-23,000
-25% -$407K ﹤0.01% 5398
2020
Q1
$1.56M Buy
90,300
+49,600
+122% +$1.04M ﹤0.01% 4548
2019
Q4
$859K Sell
40,700
-53,600
-57% -$1.09M ﹤0.01% 5873
2019
Q3
$1.84M Buy
94,300
+11,600
+14% +$213K ﹤0.01% 4602
2019
Q2
$1.44M Buy
82,700
+18,200
+28% +$328K ﹤0.01% 5094
2019
Q1
$1.19M Buy
64,500
+36,100
+127% +$644K ﹤0.01% 5268
2018
Q4
$457K Sell
28,400
-11,000
-28% -$174K ﹤0.01% 6533
2018
Q3
$587K Buy
39,400
+2,100
+6% +$30.6K ﹤0.01% 6441
2018
Q2
$524K Sell
37,300
-1,000
-3% -$13.2K ﹤0.01% 6282
2018
Q1
$498K Buy
38,300
+19,900
+108% +$255K ﹤0.01% 5894
2017
Q4
$254K Sell
18,400
-3,800
-17% -$51.4K ﹤0.01% 6720
2017
Q3
$291K Buy
+22,200
New +$286K ﹤0.01% 6113
2017
Q1
Sell
-18,900
Closed -$232K 7822
2016
Q4
$232K Buy
+18,900
New +$245K ﹤0.01% 6084
2016
Q3
Sell
-20,000
Closed -$304K 7560
2016
Q2
$304K Buy
+20,000
New +$283K ﹤0.01% 5196
2016
Q1
Sell
-29,400
Closed -$338K 7529
2015
Q4
$338K Buy
29,400
+11,000
+60% +$126K ﹤0.01% 5054
2015
Q3
$204K Sell
18,400
-3,200
-15% -$39.7K ﹤0.01% 6122
2015
Q2
$283K Buy
21,600
+8,500
+65% +$119K ﹤0.01% 5825
2015
Q1
$193K Buy
+13,100
New +$195K ﹤0.01% 6219
2014
Q4
Sell
-4,600
Closed -$56K 8642
2014
Q3
$56K Buy
4,600
+1,900
+70% +$25.3K ﹤0.01% 6836
2014
Q2
$36K Buy
+2,700
New +$35.8K ﹤0.01% 6964

Other funds holding MPT

Citadel Advisors's MPT Position: Q1 2026 in Review

Citadel Advisors increased its Medical Properties Trust (MPT) stake by 472% in Q1 2026, buying an estimated $4.99M and bringing the position to 1,159,334 shares worth $5.37M. The position accounts for ﹤0.01% of the portfolio, ranked #4232.

Citadel Advisors first reported a position in MPT in Q2 2013 and has held it in 46 quarters since. The position peaked at $56.6M in Q3 2020. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Citadel Advisors held 1,159,334 shares of Medical Properties Trust worth $5.37M as of Q1 2026.
  • Citadel Advisors bought 956,724 Medical Properties Trust shares in Q1 2026, an estimated $4.99M.
  • Medical Properties Trust made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4232 holding.
  • Citadel Advisors first reported a position in Medical Properties Trust in Q2 2013 and has held it in 46 quarters since.
  • Citadel Advisors's Medical Properties Trust position peaked at $56.6M in Q3 2020.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.